Efavirenz Mylan 600 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

efavirenz mylan 600 mg film-coated tablets

mcdermott laboratories ltd t/a gerard laboratories - efavirenz - film-coated tablet - 600 milligram(s) - non-nucleoside reverse transcriptase inhibitors; efavirenz

NuvaRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system Ireland - English - HPRA (Health Products Regulatory Authority)

nuvaring 0.120 mg/0.015 mg per 24 hours, vaginal delivery system

merck sharp & dohme ireland (human health) limited - etonogestrel; ethinylestradiol - vaginal delivery system - 0.120 mg/0.015 milligram(s)/24 hours - 5-androstanon (3) derivatives; mesterolone

STOCRIN® 50mg TABLET Singapore - English - HSA (Health Sciences Authority)

stocrin® 50mg tablet

msd pharma (singapore) pte. ltd. - efavirenz - tablet - 50.0 mg - efavirenz 50.0 mg

TIVICAY TABLET 50MG Singapore - English - HSA (Health Sciences Authority)

tivicay tablet 50mg

glaxosmithkline pte ltd - dolutegravir sodium 52.6mg eqv dolutegravir - tablet, film coated - 50mg - dolutegravir sodium 52.6mg eqv dolutegravir 50mg

Onglyza Tablets 2.5 mg Singapore - English - HSA (Health Sciences Authority)

onglyza tablets 2.5 mg

astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin - tablet, film coated - 2.5 mg - saxagliptin hydrochloride (anhydrous) 2.79 mg eqv saxagliptin 2.5 mg

Onglyza Tablets 5 mg Singapore - English - HSA (Health Sciences Authority)

onglyza tablets 5 mg

astrazeneca singapore pte ltd - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin - tablet, film coated - 5 mg - saxagliptin hydrochloride (anhydrous) 5.58 mg eqv saxagliptin 5 mg

Dutrebis 150 mg film-coated tablets lamivudine, raltegravir European Union - English - myHealthbox

dutrebis 150 mg film-coated tablets lamivudine, raltegravir

merck sharp & dohme limited - lamivudine, raltegravir potassium - film-coated tablets - 150 mg of lamivudine and 300 mg of raltegravir - hiv infections - antivirals for systemic use - indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adults, adolescents, and children from the age of 6 years and weighing at least 30 kg without present or past evidence of viral resistance to antiviral agents of the insti (integrase strand transfer inhibitor) and nrti (nucleoside reverse transcriptase inhibitor) classes

Daklinza 30 mg film-coated tablets European Union - English - myHealthbox

daklinza 30 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 30 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

Daklinza 60 mg film-coated tablets European Union - English - myHealthbox

daklinza 60 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 60 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

Cilest 35/ 250 micrograms film-coated tablets United Kingdom - English - myHealthbox

cilest 35/ 250 micrograms film-coated tablets

janssen-cilag ltd - norgestimate, ethinylestradiol - film-coated tablet - 35/ 250 micrograms - hormonal contraceptives for systemic use; progestogens and estrogens, fixed combinations - contraception and the recognised indications for such estrogen/progestogen combinations